A prescription therapy for sexual wellness that works through the nervous system, not the bloodstream — prescribed by a licensed provider and compounded for you at a US-licensed 503A pharmacy.
PT-141 (bremelanotide) is a melanocortin receptor agonist — a peptide that works through pathways in the central nervous system involved in sexual desire and arousal. Bremelanotide is the active ingredient in the FDA-approved brand medication Vyleesi®.
Unlike medications that work through blood flow, PT-141 acts on the nervous system itself. Through Quov, it's prescribed by a licensed provider after a clinical evaluation and compounded for you at a US-licensed pharmacy.
PT-141 activates melanocortin receptors in the brain involved in sexual desire and arousal — a fundamentally different mechanism than blood-flow medications.
Because it acts on arousal pathways rather than vascular function, PT-141 is studied and prescribed in the context of desire and responsiveness.
Melanocortin pathways are present in both sexes, and licensed providers prescribe PT-141 for both men and women where clinically appropriate.
1. Online consult — complete your health intake and connect with a licensed provider. 2. Provider reviews — if treatment is appropriate for you, they write your prescription. 3. Compounded for you — a US-licensed 503A pharmacy prepares your medication in a cGMP facility. 4. Delivered — shipped from the pharmacy directly to your door.
Licensed providers prescribe PT-141 (bremelanotide) for sexual wellness concerns related to desire and arousal. Whether it's appropriate for you is a clinical decision made by your provider after reviewing your health history.
Medications like sildenafil work through blood flow. PT-141 works through melanocortin receptors in the central nervous system — pathways involved in desire and arousal itself. They are fundamentally different mechanisms.
Bremelanotide — the active ingredient in PT-141 — is the active ingredient in an FDA-approved medication for premenopausal women with hypoactive sexual desire disorder. Licensed providers prescribe PT-141 for both men and women where clinically appropriate.
Yes. Through Quov, PT-141 requires evaluation by a licensed provider who determines whether treatment is appropriate for you.
No. Compounded medications are not FDA-approved. They are prepared by licensed pharmacies for individual patients pursuant to a valid prescription, under federal and state regulations.
If prescribed, your medication is compounded for you and typically ships within about a week directly from the pharmacy.
Quov is launching soon. Join the waitlist for early access and founding-member pricing on your first consult.
Join the waitlistPT-141 is available only if a licensed healthcare provider determines, after a clinical evaluation, that treatment is appropriate for you. There is no guarantee you will be prescribed any particular treatment.
Compounded medications are prepared for an individual patient pursuant to a valid prescription and are not approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Brand names referenced are trademarks of their respective owners and are used for identification of active ingredients only; Quov is not affiliated with or endorsed by their manufacturers.
The information on this page is for educational purposes only and is not medical advice. Always consult a licensed healthcare provider regarding your health.